Results 131 to 140 of about 47,532 (242)

Rapid bupropion-induced hepatotoxicity: a case report and review of the literature [PDF]

, 2018
Sulakchanan Anandabaskaran, Vincent Ho
openalex   +1 more source

Bupropion for smoking cessation in adolescents [PDF]

, 2021
Tyler D. Yan, Ran D. Goldman
openalex   +1 more source

Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown

Obesity, Volume 33, Issue S1, Page 57-73, November 2025.
ABSTRACT Objective Obesity affects 42% of older adults, with rates continuing to rise. This a complex condition influenced by non‐modifiable as well as modifiable risk factors. The disease can be treated through modifications to diet, physical activity, and behavior and more recently through antiobesity medications (AOMs) and surgery. Treatment must be
Anna Pendrey, Javier Sevilla‐Martir
wiley   +1 more source

Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers [PDF]

, 2017
Jamie N. Connarn, Stephanie A. Flowers, Marisa Kelly, Ruijuan Luo, Kristen M. Ward, Gloria Harrington, Ila Moncion, Masoud Kamali, Melivin McInnis, Meihua Rose Feng, Vicki L. Ellingrod, Andrew Babiskin, Xinyuan Zhang, Duxin Sun   +13 more
openalex   +1 more source

Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 11, November 2025.
ABSTRACT Background Long‐term antidepressant use may reduce the risk–benefit profile due to the increased likelihood of withdrawal symptoms and higher incidence of side effects. This epidemiological study investigates historical trends in long‐term antidepressant use, which was defined as maintaining continuous antidepressant use for at least 365 days,
R. A. D. L. M. K. Ranwala, Elizabeth E. Roughead, Jean‐Pierre Calabretto, Andre Q. Andrade   +3 more
wiley   +1 more source

Applicability of Raw Banana as Super Disintegrant in the Design of Bupropion HCl Orodispersible Tablets

, 2021
Chandini Vegesna, J Anu Pravallika
openalex   +1 more source

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

The Lancet, 2016
R. Anthenelli, Neal L Benowitz, R. West, L. St Aubin, T. McRae, D. Lawrence, J. Ascher, C. Russ, A. Krishen, A. E. Evins   +9 more
semanticscholar   +1 more source

Reconsidering Ondansetron for Smoking Cessation: A Call for Renewed Investigation

Pharmacology Research &Perspectives, Volume 13, Issue 6, December 2025.
Amanda Tam, Zoya Munsar, Douglas J. Opler   +2 more
wiley   +1 more source

Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial

Addiction, Volume 120, Issue 11, Page 2335-2347, November 2025.
Abstract Background and aims Despite a steady decline in smoking rates across the United Kingdom (UK) over the past decades, substantial tobacco‐related inequalities persist, particularly among individuals with mental illness. Smoking prevalence in this group has remained largely unchanged, highlighting a major public health concern.
Dimitra Kale, Emma Beard, Yan Ding, Jodi Pervin, Qi Wu, Catherine Arundel, Steve Parrott, Paul Galdas, Michelle Horspool, Simon Hough, Gregor Russell, Suzy Ker, Elena Ratschen, Lion Shahab   +13 more
wiley   +1 more source

Bupropion SR for the treatment of smokeless tobacco use

, 2007
Lowell C. Dale, Jon O. Ebbert, Elbert D. Glover, Ivana T. Croghan, Darrell R. Schroeder, Herbert H. Severson, R. Douglas Hurt   +6 more
openalex   +1 more source